Opioid growth factor ([Met5]enkephalin) prevents the incidence and retards the growth of human colon cancer

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 271, Issue 3 40-3, 1996, Pages

  Zagon, Ian S ^a,b   Hytrek, Staci D ^a   Lang, C Max ^a   Smith, Jill P ^a   Mcgarrity, Thomas J ^a   Wu, Yan ^a   Mclaughlin, Patricia J ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

gastrointestinal peptides; growth regulation; neoplasia

Indexed keywords

GASTROINTESTINAL POLYPEPTIDE; GROWTH FACTOR; METENKEPHALIN; NALOXONE; OPIATE RECEPTOR;

ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER CONTROL; CANCER GROWTH; CANCER INCIDENCE; CANCER PREVENTION; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029840010     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1996.271.3.r780     Document Type: Article

References (31)

1. Aaronson, S. A. Growth factors and cancer. Science Wash. DC 254: 1146-1153, 1991.
2. Akil, H., S. J. Watson, E. Young, M. E. Lewis, H. Katchaturian, and J. M. Walter. Endogenous opioids: biology and function. Annu. Rev. Neurosci. 7: 223-255, 1984.
3. Anzano, M. A., D. Rieman, W. Prichett, D. F. Bowen-Pope, and R. Grieg. Growth factor production by human colon carcinoma cell lines. Cancer Res. 49: 2898-2904, 1989.
4. Barg, J., M. Belcheva, R. McHale, R. Levey, Z. Vogel, and C. J. Coscia. β-endorphin is a potent inhibitor of thymidine incorporation into DNA via μ- and κ-opioid receptors in fetal rat brain cell aggregates in culture. J. Neurochem. 60: 765-767, 1993.
5. Bartolome, J. V., M. B. Bartolome, B. A. Lorber, S. J. Dileo, and S. M. Schanberg. Effects of central administration of beta-endorphin on brain and liver DNA-synthesis in preweanling rats. Neuroscience 40: 289-294, 1991.
6. Boland, C. R. The biology of colorectal cancer. Cancer 71: 4180-4186, 1993.
7. Bostwick, D. G., W. E. Null, D. Holmes, E. Weber, J. D. Barchas, and K. G. Bensch. Expression of opioid peptides in tumors. N. Engl. J. Med. 317: 1439-1443, 1987.
8. Burt, R. W., J. A. DiSario, and L. Cannon-Albright. Genetics of colon cancer: impact of inheritance on colon cancer risk. Annu. Rev. Med. 46: 371-379, 1995.
9. Coffey, R. J., G. D. Shipley, and H. L. Moses. Production of transforming growth factors by human colon cancer lines. Cancer Res. 46: 1164-1169, 1986.
10. Culouscou, J. M., R. Remacle-Bonnet, F. Garrouste, J. Fantini, J. Marvaldi, and G. Pommier. Production of insulin-like growth factor II (IGF-II) and different forms of IGF-binding proteins by HT-29 human colon carcinoma cell line. J. Cell. Physiol. 143: 405-415, 1990.
11. Fogh, J., and G. Trempe. New human tumor cell lines. In: Human Tumor Cells in Vitro, edited by J. Fogh. New York: Plenum, 1975, p. 115-159.
12. Hytrek, S. D., J. P. Smith, T. J. McGarrity, P. J. McLaughlin, C. M. Lang, and I. S. Zagon. Identification and characterization of the ζ-opioid receptor in human colon cancer. Am. J. Physiol. 271 (Regulatory Integrative Comp. Physiol. 40): R115-R121, 1996.
13. Iishi, H., M. Tatsuta, M. Baba, S. Okuda, and H. Taniguchi. Enhancement by methionine enkephalin of colon carcinogenesis induced by azoxymethane. Cancer Res. 51: 685-788, 1991.
14. Kastin, A. J., C. Nissen, A. V. Schally, and D. H. Coy. Blood-brain barrier, half-time disappearance, and brain distribution for labelled enkephalin and a potent analog. Brain Res. Bull. 1: 583-589, 1976.
15. Lahm, H., L. Suardet, P. L. Laurent, J. R. Fischer, A. Ceyhan, J. C. Givel, and N. Odartchenko. Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor alpha. Br. J. Cancer 65: 341-346, 1992.
16. 5]enkephalin. Am. J. Physiol. 271 (Regulatory Integrative Comp. Physiol. 40): R122-R129, 1996.
17. Meriney, S. D., M. J. Ford, D. Oliva, and G. Pilar. Endogenous opioids modulate neuronal survival in the developing avian ciliary ganglion. J. Neurosci. 11: 3705-3717, 1991.
18. Murgo, A. J. Inhibition of B16-BL6 melanoma growth in mice by methionine-enkephalin. J. Natl. Cancer Inst. 75: 341-344, 1985.
19. Radulovic, S., G. Miller, and A. V. Schally. Inhibition of growth of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095). Cancer Res. 51: 6006-6009, 1991.
20. + murine T cells. J. Pharmacol. Exp. Ther. 273: 1105-1113, 1995.
21. Steele, G., J. Tepper, B. T. Motwani, and H. W. Bruckner. Adenocarcinoma of the colon and rectum. In: Cancer Medicine (3rd ed.), edited by J. F. Holland, E. Frei, R. C. Bast, D. W. Kufe, D. L. Morton, and R. R. Weichselbaum. Philadelphia, PA: Lea & Febiger, 1993, p. 1493-1552.
22. Tari, A., Y. Miyachi, K. Sumii, K. Haruma, M. Yoshihara, G. Kajiyama, and A. Miyoshi. β-endorphin-like immunoreactivity in normal mucosa, muscle layer, adenocarcinoma, and polyp of the colon. Dig. Dis. Sci. 33: 429-434, 1988.
23. Villiger, P. M., and M. Lotz. Expression of prepro-enkephalin in human articular chondrocytes is linked to cell proliferation. EMBO J. 11: 135-143, 1992.
24. Vogelstein, B., E. F. Fearon, S. R. Hamilton, S. E. Kern, A. C. Preisinger, M. Leppert, Y. Nakamura, R. White, A. M. N. Smits, and J. L. Bos. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 319: 525-532, 1988.
25. Wu, Y., P. J. McLaughlin, and I. S. Zagon. Opioid growth factor and the zeta (ζ)-opioid receptor are present and function in mammalian esophagus (Abstract). FASEB J. 10: A771, 1996.
26. Zagon, I. S., S. D. Hytrek, and P. J. McLaughlin. Opioid growth factor tonically inhibits human colon cancer cell proliferation in tissue culture. Am. J. Physiol. 271 (Regulatory Integrative Comp. Physiol. 40): R511-R518, 1996.
27. Zagon, I. S., and P. J. McLaughlin. The role of endogenous opioids and opioid receptors in human and animal cancers. In: Stress and Immunity, edited by N. P. Plotnikoff, A. J. Murgo, R. E. Faith, and J. Wybran. Caldwell, NJ: CRC, 1991, p. 343-356.
28. Zagon, I. S., and P. J. McLaughlin. Opioid growth factor receptor in the developing nervous system. In: Receptors in the Developing Nervous System. Growth Factors and Hormones, edited by I. S. Zagon and P. J. McLaughlin. London: Chapman and Hall, 1993, vol. 1, p. 39-62.
29. Zagon, I. S., P. J. McLaughlin, S. R. Goodman, and R. E. Rhodes. Opioid receptors and endogenous opioids in diverse human and animal cancers. J. Natl. Cancer Inst. 79: 1059-1065, 1987.
30. 5]-enkephalin, and the zeta (ζ) opioid receptor in vertebrate cornea. Brain Res. 671: 105-111, 1995.
31. Zagon, I. S., J. W. Sassani, and P. J. McLaughlin. Opioid growth factor modulates corneal epithelial outgrowth in tissue culture. Am. J. Physiol. 268 (Regulatory Integrative Comp. Physiol. 37): R942-R950, 1995.